{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:32:33Z","timestamp":1793111553460,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007206","name":"Vanderbilt Institute for Clinical and Translational Research","doi-asserted-by":"publisher","award":["NIH UL1-TR000445"],"award-info":[{"award-number":["NIH UL1-TR000445"]}],"id":[{"id":"10.13039\/100007206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["G4A- 177741"],"award-info":[{"award-number":["G4A- 177741"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["autonomicneuroscience.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autonomic Neuroscience"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.autneu.2026.103480","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:01:05Z","timestamp":1788188465000},"page":"103480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Methyldopa for hyperadrenergic postural orthostatic tachycardia syndrome: A case series of five patients"],"prefix":"10.1016","volume":"268","author":[{"given":"Adrian","family":"Handy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmin","family":"Hira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Sheldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish R.","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autneu.2026.103480_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.autneu.2018.02.005","article-title":"Postural tachycardia syndrome - diagnosis, physiology, and prognosis","volume":"215","author":"Arnold","year":"2018","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.autneu.2026.103480_bb0010","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1161\/ATVBAHA.111.244343","article-title":"Epigenetic modification of the norepinephrine transporter gene in postural tachycardia syndrome","volume":"32","author":"Bayles","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.autneu.2026.103480_bb0015","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4065\/77.6.531","article-title":"Quality of life in patients with postural tachycardia syndrome","volume":"77","author":"Benrud-Larson","year":"2002","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.autneu.2026.103480_bb0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41380-021-01148-4","article-title":"Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis?","volume":"27","author":"Bornstein","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.autneu.2026.103480_bb0025","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10286-019-00606-y","article-title":"A practical guide to active stand testing and analysis using continuous beat-to-beat non-invasive blood pressure monitoring","volume":"29","author":"Finucane","year":"2019","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.autneu.2026.103480_bb0030","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1212\/01.wnl.0000267663.05398.40","article-title":"The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome","volume":"69","author":"Garland","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.autneu.2026.103480_bb0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.autneu.2018.04.004","article-title":"Evaluation of postural tachycardia syndrome (POTS)","volume":"215","author":"Goodman","year":"2018","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.autneu.2026.103480_bb0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF02291387","article-title":"Hemodynamic and symptomatic effects of acute interventions on tilt in patients with postural tachycardia syndrome","volume":"10","author":"Gordon","year":"2000","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.autneu.2026.103480_bb0045","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/bcpt.12622","article-title":"Paracelsus revisited: the dose concept in a complex world","volume":"119","author":"Grandjean","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.autneu.2026.103480_bb0050","first-page":"767","article-title":"Objective hemodynamic cardiovascular autonomic abnormalities in post-acute sequelae of COVID-19","volume":"39","author":"Hira","year":"2023","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.autneu.2026.103480_bb0055","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s11910-023-01320-z","article-title":"Autonomic manifestations of long-COVID syndrome","volume":"23","author":"Hira","year":"2023","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.autneu.2026.103480_bb0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10286-022-00897-8","article-title":"Consensus statement on the definition of orthostatic hypertension endorsed by the American Autonomic Society and the Japanese Society of Hypertension","volume":"33","author":"Jordan","year":"2023","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.autneu.2026.103480_bb0065","doi-asserted-by":"crossref","first-page":"527","DOI":"10.5603\/CJ.2011.0008","article-title":"Clinical presentation and management of patients with hyperadrenergic postural orthostatic tachycardia syndrome. A single center experience","volume":"18","author":"Kanjwal","year":"2011","journal-title":"Cardiol. J."},{"key":"10.1016\/j.autneu.2026.103480_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.autneu.2022.103052","article-title":"Self-reported symptom burden in postural orthostatic tachycardia syndrome (POTS): a narrative review of observational and interventional studies","volume":"244","author":"Knoop","year":"2023","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.autneu.2026.103480_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003893.pub2","article-title":"Methyldopa for primary hypertension","volume":"2009","author":"Mah","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.autneu.2026.103480_bb0080","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-med-041818-011630","article-title":"Postural orthostatic tachycardia syndrome: mechanisms and new therapies","volume":"71","author":"Mar","year":"2020","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.autneu.2026.103480_bb0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s40814-020-00702-1","article-title":"Protocol for a randomised controlled feasibility trial of exercise rehabilitation for people with postural tachycardia syndrome: the PULSE study","volume":"6","author":"McGregor","year":"2020","journal-title":"Pilot Feasibility Stud."},{"key":"10.1016\/j.autneu.2026.103480_bb0090","article-title":"Quantitative autonomic testing","volume":"2502","author":"Novak","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.autneu.2026.103480_bb0095","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1161\/HYPERTENSIONAHA.124.23035","article-title":"Hyperadrenergic postural tachycardia syndrome: clinical biomarkers and response to guanfacine","volume":"81","author":"Okamoto","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.autneu.2026.103480_bb0100","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/j.hrthm.2022.07.014","article-title":"Postural orthostatic tachycardia syndrome as a sequela of COVID-19","volume":"19","author":"Ormiston","year":"2022","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.autneu.2026.103480_bb0105","first-page":"357","article-title":"Canadian cardiovascular society position statement on postural orthostatic tachycardia syndrome (POTS) and related disorders of chronic orthostatic intolerance","volume":"36","author":"Raj","year":"2020","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.autneu.2026.103480_bb0110","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10286-021-00798-2","article-title":"Long-COVID postural tachycardia syndrome: an American Autonomic Society statement","volume":"31","author":"Raj","year":"2021","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.autneu.2026.103480_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jns.2017.03.032","article-title":"Quantitative assessment of autonomic symptom burden in Postural tachycardia syndrome (POTS)","volume":"377","author":"Rea","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.autneu.2026.103480_bb0120","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1056\/NEJM200002243420803","article-title":"Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency","volume":"342","author":"Shannon","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.autneu.2026.103480_bb0125","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/joim.12895","article-title":"The face of postural tachycardia syndrome - insights from a large cross-sectional online community-based survey","volume":"286","author":"Shaw","year":"2019","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.autneu.2026.103480_bb0130","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.hrthm.2015.03.029","article-title":"2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope","volume":"12","author":"Sheldon","year":"2015","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.autneu.2026.103480_bb0135","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/01.HYP.0000158259.68614.40","article-title":"Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders","volume":"45","author":"Shibao","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.autneu.2026.103480_bb0140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/joim.13566","article-title":"Malm\u00f6 POTS symptom score: assessing symptom burden in postural orthostatic tachycardia syndrome","volume":"293","author":"Spahic","year":"2023","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.autneu.2026.103480_bb0145","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41440-018-0016-6","article-title":"Co-treatment with clonidine and a GRK2 inhibitor prevented rebound hypertension and endothelial dysfunction after withdrawal in diabetes","volume":"41","author":"Taguchi","year":"2018","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.autneu.2026.103480_bb0150","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jacc.2020.12.029","article-title":"Randomized trial of ivabradine in patients with hyperadrenergic postural orthostatic tachycardia syndrome","volume":"77","author":"Taub","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.autneu.2026.103480_bb0155","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/ped.12392","article-title":"Clinical features of hyperadrenergic postural tachycardia syndrome in children","volume":"56","author":"Zhang","year":"2014","journal-title":"Pediatr. Int."}],"container-title":["Autonomic Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1566070226001025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1566070226001025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:35:09Z","timestamp":1793108109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1566070226001025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":31,"alternative-id":["S1566070226001025"],"URL":"https:\/\/doi.org\/10.1016\/j.autneu.2026.103480","relation":{},"ISSN":["1566-0702"],"issn-type":[{"value":"1566-0702","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methyldopa for hyperadrenergic postural orthostatic tachycardia syndrome: A case series of five patients","name":"articletitle","label":"Article Title"},{"value":"Autonomic Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autneu.2026.103480","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103480"}}